IRADIMED CORPORATION(NasdaqGM:IRMD) added to S&P Healthcare Equipment Select Industry Index

Market Closed –
|
5-day change | 1st Jan Change | ||
70.71 USD |
+0.27% |
|
-1.26% | +28.56% |
Published on 09/21/2025
at 10:20 pm EDT
S&P Capital IQ
+0.27%

IRADIMED CORPORATION(NasdaqGM:IRMD) added to S&P Healthcare Equipment Select Industry Index
IRADIMED CORPORATION(NasdaqGM:IRMD) added to S&P Healthcare Equipment Select Industry Index |
Sep. 21 |
CI |
IRADIMED CORPORATION Announces Board Changes |
Sep. 02 |
CI |
IRADIMED CORPORATION, Q2 2025 Earnings Call, Aug 01, 2025 |
Aug. 01 |
|
Iradimed Corporation Provides Earnings Guidance for the Third Quarter and Full Year of 2025 |
Aug. 01 |
CI |
Iradimed Corporation Revises Earnings Guidance for the Full Year of 2025 |
Aug. 01 |
CI |
IRADIMED Corporation Declares Regular Quarterly Cash Dividend for the Third Quarter of 2025, Payable on August 28, 2025 |
Aug. 01 |
CI |
Iradimed Q2 Adjusted Earnings, Revenue Rise; Raises 2025 Outlook |
Aug. 01 |
MT |
IRADIMED CORPORATION Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 |
Aug. 01 |
CI |
Sector Update: Health Care Stocks Higher Late Afternoon |
May. 29 |
MT |
Sector Update: Health Care Stocks Higher Thursday Afternoon |
May. 29 |
MT |
Iradimed Says MRidium 3870 IV Infusion Pump System Gets FDA Clearance; Shares Up |
May. 29 |
MT |
IRADIMED CORPORATION Announces FDA 510(k) Clearance for MRidium® 3870 Infusion Pump System |
May. 29 |
CI |
IRADIMED CORPORATION, Q1 2025 Earnings Call, May 05, 2025 |
May. 05 |
|
Iradimed Corporation Provides Earnings Guidance for the Second Quarter and Reiterates Earnings Guidance for the Full Year of 2025 |
May. 05 |
CI |
IRADIMED CORPORATION Declares Quarterly Cash Dividend, Payable on May 30, 2025 |
May. 05 |
CI |
IRADIMED CORPORATION Reports Earnings Results for the First Quarter Ended March 31, 2025 |
May. 05 |
CI |
IRadimed Raises Quarterly Dividend to $0.17 a Share From $0.15, Payable March 5 to Shareholders as of Feb. 24 |
Feb. 13 |
MT |
IRADIMED CORPORATION, Q4 2024 Earnings Call, Feb 13, 2025 |
Feb. 13 |
|
IRADIMED CORPORATION Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 |
Feb. 13 |
CI |
IRADIMED CORPORATION Declares Regular Quarterly Cash Dividend for the First Quarter of 2025, Payable on March 5, 2025 |
Feb. 13 |
CI |
IRADIMED CORPORATION Provides Earnings Guidance for the First Quarter and Full Year 2025 |
Feb. 13 |
CI |
IRADIMED CORPORATION Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 05:15 PM |
Jan. 15 |
|
IRADIMED CORPORATION Provides Earnings Guidance for the Fourth Quarter and Full Year 2024 |
Jan. 10 |
CI |
IRADIMED CORPORATION, Q3 2024 Earnings Call, Oct 31, 2024 |
24-10-31 |
|
Earnings Flash (IRMD) IRADIMED CORPORATION Posts Q3 Revenue $18.3M |
24-10-31 |
MT |
IRMD: Dynamic Chart
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patientâs vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gausses.
More about the company

Buy
Average target price
73.50USD
Spread / Average Target
+3.95%
Consensus
Quarterly revenue – Rate of surprise
Select your edition
All financial news and data tailored to specific country editions
link